These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22149573)

  • 1. Medical therapy for nonalcoholic fatty liver disease in children and adolescents.
    Andrews DB; Lavine JE
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):1-3. PubMed ID: 22149573
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
    Gawrieh S; Harlow KE; Pike F; Yates KP; Wilson LA; Cummings OW; Rosenberg WM; Chalasani N; Molleston JP
    J Pediatr; 2021 Dec; 239():161-167.e5. PubMed ID: 34400208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.
    Lavine JE; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):129-30. PubMed ID: 16456401
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
    Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
    JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
    Kadayifci A; Merriman RB
    Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way?
    Alisi A; Nobili V
    Nat Rev Gastroenterol Hepatol; 2011 Jul; 8(8):425-6. PubMed ID: 21750513
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy for nonalcoholic fatty liver disease].
    Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):139. PubMed ID: 15727706
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
    Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
    Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E for nonalcoholic fatty liver disease.
    Mullin GE
    Nutr Clin Pract; 2011 Oct; 26(5):636-7. PubMed ID: 21947647
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
    Socha P; Horvath A; Vajro P; Dziechciarz P; Dhawan A; Szajewska H
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):587-96. PubMed ID: 19412008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
    Patton HM; Lavine JE; Van Natta ML; Schwimmer JB; Kleiner D; Molleston J;
    Gastroenterology; 2008 Dec; 135(6):1961-1971.e2. PubMed ID: 19013463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
    Lavine JE; Schwimmer JB; Molleston JP; Scheimann AO; Murray KF; Abrams SH; Rosenthal P; Sanyal AJ; Robuck PR; Brunt EM; Unalp A; Tonascia J;
    Contemp Clin Trials; 2010 Jan; 31(1):62-70. PubMed ID: 19761871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response.
    Argo CK; Ikura Y; Lackner C; Caldwell SH
    Hepatology; 2016 Mar; 63(3):1056-7. PubMed ID: 26206460
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease.
    Omer Z; Cetinkalp S; Akyildiz M; Yilmaz F; Batur Y; Yilmaz C; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):18-23. PubMed ID: 19667999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease.
    Barbero-Becerra VJ; Santiago-Hernandez JJ; Villegas-Lopez FA; Mendez-Sanchez N; Uribe M; Chavez-Tapia NC
    Curr Med Chem; 2012; 19(18):2918-23. PubMed ID: 22519397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
    Adams LA; Angulo P
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1059-60. PubMed ID: 15625648
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
    Said A; Akhter A
    Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.